Table 1 Baseline and clinical characteristics of patients and their correlation with Endostar
Characteristics | CCRT group | CCRT+Endostar group | P Value |
|---|---|---|---|
Age(mean±sd) | 59.08±10.062 | 62.15±8.602 | 0.357 |
Gender | Â | Â | 0.911 |
Male | 65(62.5) | 39(37.5) | Â |
Female | 11(61.1) | 7(38.9) | Â |
Smoking | Â | Â | 0.928 |
Non-smoker | 16(61.5) | 10(38.5) | Â |
Smoker | 60(62.5) | 36(37.5) | Â |
Pathology | Â | Â | 0.844 |
Squamous | 59(62.8) | 35(37.2) | Â |
Adenocarcinoma | 17(60.7) | 11(39.3) | Â |
Stage | Â | Â | 0.711 |
IIIA | 34(64.2) | 19(35.8) | Â |
IIIB | 42(60.9) | 27(39.1) | Â |
Amifostine | Â | Â | 0.304 |
No | 53(59.6) | 36(40.4) | Â |
Yes | 23(69.7) | 10(30.3) | Â |
GTV(cm3) | Â | Â | 0.062 |
<503.5(median) | 43(70.5) | 18(29.5) | Â |
≥503.5(median) | 33(54.1) | 28(45.9) |  |
Total lung MLD(cGy) | Â | Â | 0.161 |
<1450.7(median) | 38(69.1) | 17(30.9) | Â |
≥1450.7(median) | 38(56.7) | 29(43.3) |  |
V20Gy (%) | Â | Â | 0.036* |
<25% | 33(53.2) | 29(46.8) | Â |
≥25% | 43(71.7) | 17(28.3) |  |